Filters: keyword is Morphine [Clear All Filters]
- 2007
Influence of biophase distribution and P-glycoprotein interaction on pharmacokinetic-pharmacodynamic modelling of the effects of morphine on the EEG,
Br J Pharmacol, vol. 151, no. 5, pp. 713-20.
- 2005
Transdermal iontophoretic delivery of apomorphine in patients improved by surfactant formulation pretreatment,
J Control Release, vol. 101, no. 1-3, pp. 199-208.
High-performance liquid chromatography of nalbuphine, butorphanol and morphine in blood and brain microdialysate samples: application to pharmacokinetic/pharmacodynamic studies in rats,
J Chromatogr B Analyt Technol Biomed Life Sci, vol. 822, no. 1-2, pp. 230-7.
- 2004
Compartmental modeling of transdermal iontophoretic transport: I. In vitro model derivation and application,
Pharm Res, vol. 21, no. 11, pp. 1974-84.
- 2003
Iontophoretic R-apomorphine delivery in combination with surfactant pretreatment: in vitro validation studies,
Int J Pharm, vol. 266, no. 1-2, pp. 61-8.
Pretreatment with a water-based surfactant formulation affects transdermal iontophoretic delivery of R-apomorphine in vitro,
Pharm Res, vol. 20, no. 4, pp. 653-9.
- 2002
In vitro iontophoresis of R-apomorphine across human stratum corneum. Structure-transport relationship of penetration enhancement,
J Control Release, vol. 84, no. 1-2, pp. 49-57.
- 2001
Effect of elastic liquid-state vesicle on apomorphine iontophoresis transport through human skin in vitro,
Pharm Res, vol. 18, no. 11, pp. 1627-30.
Lontophoretic delivery of apomorphine in vitro: physicochemic considerations,
Pharm Res, vol. 18, no. 11, pp. 1509-13.
- 1999
Future delivery systems for apomorphine in patients with Parkinson's disease,
Adv Neurol, vol. 80, pp. 535-44.
- 1998
Pharmacokinetics, enantiomer interconversion, and metabolism of R-apomorphine in patients with idiopathic Parkinson's disease,
Clin Neuropharmacol, vol. 21, no. 3, pp. 159-68.
Stepwise intravenous infusion of apomorphine to determine the therapeutic window in patients with Parkinson's disease,
Clin Neuropharmacol, vol. 21, no. 3, pp. 152-8.
Validation and testing of a new iontophoretic continuous flow through transport cell,
J Control Release, vol. 51, no. 1, pp. 85-91.
- 1997
Assay of R-apomorphine, S-apomorphine, apocodeine, isoapocodeine and their glucuronide and sulfate conjugates in plasma and urine of patients with Parkinson's disease,
J Chromatogr B Biomed Sci Appl, vol. 702, no. 1-2, pp. 131-41.
Iontophoretic delivery of apomorphine. I: In vitro optimization and validation,
Pharm Res, vol. 14, no. 12, pp. 1798-803.
Iontophoretic delivery of apomorphine. II: An in vivo study in patients with Parkinson's disease,
Pharm Res, vol. 14, no. 12, pp. 1804-10.
- 1996
A new sublingual formulation of apomorphine in the treatment of patients with Parkinson's disease,
Mov Disord, vol. 11, no. 6, pp. 633-8.
- 1995
Pharmacokinetics and clinical efficacy of rectal apomorphine in patients with Parkinson's disease: a study of five different suppositories,
Mov Disord, vol. 10, no. 4, pp. 433-9.
